Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  nanoparticle albumin-bound rapamycin
Find trials that include:  Any drugs shown
Results 1-4 of 4 for your search:
Start Over
Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: Over 18
Trial IDs: BC001, NCI-2015-01102, 1R42CA171552-01, NCT02009332
A Phase 2 Study of ABI-009 in Patients With Advanced Malignant PEComa
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: PEC001, NCI-2015-02284, NCT02494570
Nanoparticle Albumin-Bound Rapamycin in Treating Patients with Advanced Cancer with mTOR Mutations
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC1313, NCI-2015-02151, NCT02646319
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients with Recurrent or Refractory Solid Tumors
Status: Active
Phase: Phase I
Type: Treatment
Age: 12 months to 21 years
Trial IDs: ADVL1514, NCI-2016-01412, NCT02975882
Start Over